Literature DB >> 28878840

Chronic Venous Insufficiency: a Frequently Underdiagnosed and Undertreated Pathology.

Marilena Spiridon1, Dana Corduneanu2.   

Abstract

The article describes the medical approach of a frequent pathology, chronic venous insufficiency. Chronic venous insufficiency requires early diagnosis as well as an evaluation of the associated risk factors; also, patients need to understand the disease and its treatment, and to become compliant with all their physician's recommendations. Importantly, the physician should correctly evaluate the disease and decide the best option for the patient. These days, it is crucial that the patient benefits from optimal treatment choice in order to prevent complications. CVI is a potentially severe pathology that has been underdiagnosed and undertreated for a long time and requires patience from the patient as well as care from the physician.

Entities:  

Year:  2017        PMID: 28878840      PMCID: PMC5574075     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  2 in total

Review 1.  Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.

Authors:  M Perrin; A A Ramelet
Journal:  Eur J Vasc Endovasc Surg       Date:  2010-12-03       Impact factor: 7.069

Review 2.  Pharmacological profile of sulodexide.

Authors:  D A Hoppensteadt; J Fareed
Journal:  Int Angiol       Date:  2014-06       Impact factor: 2.789

  2 in total
  4 in total

1.  Classification of reflux patterns in patients with great saphenous vein insufficiency and correlation with clinical severity.

Authors:  Sezen Yılmaz; Burçak Çakır Peköz; Neris Dincer; Sinan Deniz; Levent Oğuzkurt
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

2.  In vitro and ex vivo evaluation of the biological performance of sclerosing foams.

Authors:  Elisabetta Bottaro; Jemma A J Paterson; Luciano Quercia; Xunli Zhang; Martyn Hill; Venisha A Patel; Stephen A Jones; Andrew L Lewis; Timothy M Millar; Dario Carugo
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

3.  Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus.

Authors:  Xiaxuan Huang; Luming Zhang; Mengyuan Xu; Shiqi Yuan; Yan Ye; Tao Huang; Haiyan Yin; Jun Lyu
Journal:  Front Cardiovasc Med       Date:  2022-07-19

4.  Low-level laser therapy for treatment of venous ulcers evaluated with the Nursing Outcome Classification: study protocol for a randomized controlled trial.

Authors:  Taline Bavaresco; Ananda Ughini Bertoldo Pires; Vítor Monteiro Moraes; Viviane Maria Osmarin; Denise Tolfo Silveira; Amália de Fátima Lucena
Journal:  Trials       Date:  2018-07-12       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.